Related Experiment Video
Updated: Jun 5, 2026
07:21
Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
Blood-based diagnostics of traumatic brain injuries
Stefania Mondello1, Uwe Muller, Andreas Jeromin
1Banyan Biomarkers, Inc., 12085 Research Drive, Alachua, FL 32615, USA.
Expert Review of Molecular Diagnostics
|December 22, 2010
Summary
New biomarkers offer hope for diagnosing and monitoring traumatic brain injury (TBI). Research in proteomics advances understanding of TBI mechanisms, aiding patient care.
Area of Science:
- Neuroscience
- Biochemistry
- Medical Diagnostics
Background:
- Traumatic brain injury (TBI) presents significant global health and socioeconomic challenges.
- Current TBI severity classifications face debate and require enhancement with advanced imaging.
- There is a recognized need for biomarkers reflecting the pathogenetic processes of TBI.
Purpose of the Study:
- To review recent advancements in TBI biomarkers.
- To discuss current knowledge, controversies, and the potential of novel biomarkers.
- To explore the role of biomarkers in diagnosing, prognosing, and monitoring TBI patients.
Main Methods:
- Review of basic science research in TBI.
- Analysis of developments in proteomics for biomarker discovery.
- Synthesis of current literature on neuroimaging and proteomic biomarkers for TBI.
Main Results:
- Proteomics research has significantly improved understanding of TBI mechanisms.
- New biomarkers for TBI have been discovered and can be rapidly detected.
- Translating these research findings into clinical patient benefits remains an ongoing challenge.
Conclusions:
- Novel biomarkers show promise for improving TBI diagnosis and prognosis.
- Biomarkers can potentially aid in monitoring patient recovery and treatment response.
- Further research is needed to fully integrate these biomarkers into clinical practice for TBI management.
